Detalhe da pesquisa
1.
Identification of incidental brain tumors in prostate cancer patients via PSMA PET/CT.
J Neurooncol
; 163(2): 455-462, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37247180
2.
Influence of hydrogel spacer placement with prostate brachytherapy on rectal and urinary toxicity.
BJU Int
; 129(3): 337-344, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388295
3.
Oncologic Outcomes after Localized Prostate Cancer Treatment: Associations with Pretreatment Prostate Magnetic Resonance Imaging Findings.
J Urol
; 205(4): 1055-1062, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33207133
4.
Association between Site-of-Care and the Cost and Modality of Radiotherapy for Prostate Cancer: Analysis of Medicare Beneficiaries from 2015 to 2017.
Cancer Invest
; 39(2): 144-152, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416007
5.
Sildenafil Citrate and Risk of Biochemical Recurrence in Prostate Cancer Patients Treated with Radiation Therapy: Post-Hoc Analysis of a Randomized Controlled Trial.
J Sex Med
; 18(8): 1467-1472, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37057447
6.
American Cancer Society prostate cancer survivorship care guidelines.
CA Cancer J Clin
; 64(4): 225-49, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24916760
7.
Prognostic Value of Pretreatment MRI in Patients With Prostate Cancer Treated With Radiation Therapy: A Systematic Review and Meta-Analysis.
AJR Am J Roentgenol
; 214(3): 597-604, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31799874
8.
Long-Term Implications of a Positive Posttreatment Biopsy in Patients Treated with External Beam Radiotherapy for Clinically Localized Prostate Cancer.
J Urol
; 201(6): 1127-1133, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30741847
9.
Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer.
BJU Int
; 120(5B): E87-E95, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28464446
10.
Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy.
Neurosurg Focus
; 42(1): E9, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28041318
11.
The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.
Neurosurg Focus
; 42(1): E6, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28041329
12.
Genomic characterization of response to chemoradiation in urothelial bladder cancer.
Cancer
; 122(23): 3715-3723, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27479538
13.
Predictors of castration-resistant prostate cancer after dose-escalated external beam radiotherapy.
Prostate
; 75(2): 175-82, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25327412
14.
Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.
J Urol
; 194(6): 1624-30, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26165583
15.
Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.
Ann Surg Oncol
; 22(7): 2168-78, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25631062
16.
Cigarette smoking during external beam radiation therapy for prostate cancer is associated with an increased risk of prostate cancer-specific mortality and treatment-related toxicity.
BJU Int
; 116(4): 596-603, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25345838
17.
Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRI.
Eur Radiol
; 25(9): 2665-72, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25820537
18.
Utility of FDG-PET in clinical neuroendocrine prostate cancer.
Prostate
; 74(11): 1153-9, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24913988
19.
Prophylactic sildenafil citrate improves select aspects of sexual function in men treated with radiotherapy for prostate cancer.
J Urol
; 192(3): 868-74, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24603102
20.
Comparison of high-dose (86.4 Gy) IMRT vs combined brachytherapy plus IMRT for intermediate-risk prostate cancer.
BJU Int
; 114(3): 360-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24447404